After Hours
$
101.01
Change
-0.33 -0.33%
Volume
Volume 34,093
Dec 6, 2023, 5:55 p.m.
Quotes are delayed by 20 min
Today's close
$ 98.74
$ 101.34
Change
+2.60 +2.63%
Day low
Day high
$97.61
$102.51

52 week low
52 week high
$88.00
$188.99

Market cap
$23.47B
Average volume
684,497
P/E ratio
8.80
Rev. per Employee
$1.52M
EPS
11.51
Dividend
N/A
Div yield
N/A
Ex dividend date
6/2/22
MarketWatch News on BNTX
-
BioNTech downgraded to underweight from neutral at J.P. Morgan
- Tomi Kilgore
-
A Golden Age of Vaccines Is Here. What It Means for You.
- Neal Templin
-
BioNTech now sees full-year COVID vaccine revenues of EUR4 bln vs. EUR5 bln previously
- Ciara Linnane
-
BioNTech Q3 EPS EUR0.67; FactSet consensus loss of 59 cents a share
- Ciara Linnane
-
BioNTech Q3 revenue EUR895.3 mln; FactSet consensus EUR851.0 mln
- Ciara Linnane
-
Disney, Uber, and More to Watch This Week
- Nicholas Jasinski
-
- Janet H. Cho
-
Pfizer and BioNTech announce positive data from flu/COVID combination vaccine
- Ciara Linnane
- Loading more headlines...
Other News on BNTX
-
- The Wall Street Journal Interactive Edition
-
The Covid Vaccine Windfall Turns for Pfizer and Moderna
- The Wall Street Journal Interactive Edition
-
When to Get Your Covid-19, Flu and RSV Shots This Fall
- The Wall Street Journal Interactive Edition
-
After Shunning Scientist, University of Pennsylvania Celebrates Her Nobel Prize
- The Wall Street Journal Interactive Edition
-
FDA Authorizes Novavax’s Updated Covid Vaccine
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Pioneers of mRNA Find Redemption in Nobel Prize
- The Wall Street Journal Interactive Edition
-
FDA Approves Newest Covid-19 Boosters
- The Wall Street Journal Interactive Edition
-
Germany Is Losing Its Mojo. Finding It Again Won’t Be Easy.
- The Wall Street Journal Interactive Edition
-
Stock Index Orphans Miss Out on Billions of Dollars From Passive Investors
- The Wall Street Journal Interactive Edition
-
‘Programmable Planet’ Review: Biology’s Big Bonus
- The Wall Street Journal Interactive Edition
-
A New Omicron Subvariant, Dubbed ‘Eris,’ Heralds Covid-19’s Resurgence
- The Wall Street Journal Interactive Edition
-
A New Omicron Subvariant, Dubbed ‘Eris,’ Heralds Covid-19’s Resurgence
- The Wall Street Journal Interactive Edition
-
Pfizer’s Covid Boost Crashes to Earth
- The Wall Street Journal Interactive Edition
-
Next Covid Shots in the U.S. Will Target Omicron Offshoot XBB.1.5
- The Wall Street Journal Interactive Edition
-
U.S. to Target XBB Strain When Covid Shots Roll Out This Fall
- The Wall Street Journal Interactive Edition
-
Vaccine Fatigue Can Give Your Portfolio a Booster
- The Wall Street Journal Interactive Edition
-
Next Covid Boosters to Target New Strain
- The Wall Street Journal Interactive Edition
-
Pfizer’s Earnings Fall With Cooling Demand for Covid-19 Products
- The Wall Street Journal Interactive Edition
-
New Covid-19 Booster Shots: What to Know
- The Wall Street Journal Interactive Edition
- Loading more headlines...
Press Releases on BNTX
-
BioNTech Announces New ADS Repurchase Program
- GlobeNewswire
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com